HHS on Thursday (Dec. 4) announced its novel artificial intelligence “OneHHS” approach to further integrate machine learning technologies into the health care system through coordination across federal health agencies’ workforce, internal operations and research.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Home
Focus On ACIP
At Chaotic Meeting, ACIP Again Stalls Vote On Hep B Vaccine
The Advisory Committee on Immunization Practices has again delayed voting on whether to revoke the recommendation for universal administration of the hepatitis B vaccine at birth, with members of the CDC committee confused about the voting language.
Cassidy: ACIP ‘Totally Discredited’ With Aaron Siri Scheduled To Speak
PhRMA Joins Chorus Of Alarm Ahead Of ACIP Meeting
FDA News
12 Former Top FDA Officials Lambast Prasad’s Vaccine Policy Shifts
Twelve former commissioners and acting commissioners of FDA authored a joint statement Wednesday (Dec. 3) warning biologics center chief Vinay Prasad’s major policy shifts undermine a longstanding regulatory model designed to ensure vaccines are “safe, effective, and available when the public needs them most.”
Key Makary Ally Tracy Beth Høeg Named Acting Head Of CDER
FDA Shifts OTC Leader In Bid To Refocus Office On Affordability
Latest News
HHS is encouraging employees across its agencies to begin using artificial intelligence tool Claude Government in addition to ChatGPT, according to an internal email sent Wednesday (Dec. 3) by Deputy Secretary Jim O’Neill and obtained by Inside Health Policy.
The National Institutes of Health is holding off on onboarding new staff despite the Oct. 15 end of the full-time equivalent hiring freeze, as the agency awaits direction from HHS’ newly required “strategic hiring committee,” sources tell Inside Health Policy.
In accusations that largely match rhetoric from HHS Secretary Robert F. Kennedy Jr., the city of San Francisco has filed a lawsuit against food manufacturers for marketing ultraprocessed foods, claiming they violated California unfair competition and public nuisance laws because the foods are addictive and the makers deprived consumers of informed choice.
CMS will publish a proposal in the Federal Register this week that would allow Medicare Advantage plans to cover certain hemp-derived cannabidiol (CBD) products that comply with state and federal law, a major reversal that could significantly expand seniors’ access to alternative therapies.
FDA is requesting input on how the agency could increase patients’ access to nonprescription drugs in preparation for a public meeting on the topic in 2026.